Statins (HMG-CoA reductase inhibitors), cholesterol and stroke;Estatinas (inhibidores dela HMG-CoA reductasa), colesterol e ictus

Revista de Neurologia

Volumn 27, Issue 159, 1998, Pages 827-830

  Marta Moreno, J ^a   Echeandia, C ^a   Oliveros Cid, A ^a   Figuerola, A ^a   Mola, S ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Cerebral ischemia; Cholesterol; HMG CoA reductase; Stroke

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PRAVASTATIN; SIMVASTATIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MEVINOLIN; TRIACYLGLYCEROL;

BRAIN INFARCTION; CLINICAL TRIAL; HUMAN; HYPERCHOLESTEROLEMIA; MORBIDITY; MORTALITY; REVIEW; STROKE; TRANSIENT ISCHEMIC ATTACK; ADULT; ARTERIOSCLEROSIS; BLOOD; CEREBROVASCULAR DISEASE; DRUG SCREENING; FEMALE; MALE; MIDDLE AGED; RISK FACTOR;

ADULT; ARTERIOSCLEROSIS; CEREBROVASCULAR DISORDERS; CHOLESTEROL; CLINICAL TRIALS; DRUG EVALUATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; ISCHEMIC ATTACK, TRANSIENT; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LOVASTATIN; MALE; MIDDLE AGED; PRAVASTATIN; RISK FACTORS; SIMVASTATIN; TRIGLYCERIDES;

EID: 0031593755     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.27159.98262     Document Type: Review

References (28)

1. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
2. Scandinavian Simvastatin Survival Study Group. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet 1995; 345: 1274-5.
3. Sacks FM, Pfeffer MA, Moye LA, et al. For the Cholesterol and Recurrent Events Trial Investigators (CARE). The effect of pravastatin on coronary events after a myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-9.
4. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with Pravastatin in men with hypercholesterolaemia. West of Scotland Coronary Prevention Study. New Engl J Med 1995; 333: 1301-7.
5. Downs JR, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. AirForce/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279: 1615-22.
6. Blauw GJ, Lagaay AM, Smelt AHM, Westendorp RG. Stroke, Statins and Cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke 1997; 28: 946-50.
7. Crouse JR, Byington RP, Hoen HM, Furberg CD. Reductase Inhibitor Monotherapy and Stroke Prevention. Arch Intern Med 1997; 157: 1305-10.
8. Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total Mortality. An Overview of Randomized Trials. JAMA 1997; 278: 313-21.
9. Oliver MF. Might treatment of hypercholesterolaemia increase non-cardiac mortality? Lancet 1991; 337: 1529-31.
10. Gaziano JM, Hebert PR, Hennekens CH. Cholesterol reduction: weighing the benefits and risks. Ann Intern Med 1996; 124: 914-8.
11. Bucher HC, Griffith LE, Guyatt GH. Effect of HMGcoA Reductase inhibitors on Stroke. A Meta-Analysis of Randomized, Controlled Trials. Ann Intern Med 1998; 128: 89-95.
12. Crouse JR, Byington RP, Bond MH, et al. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC II). Am J Cardiol 1995; 75: 455-9.
13. Furberg C, Adams HP, Applegate WB, et al. Effect of Lovastatin on Early Carotid Atherosclerosis and Cardiovascular Events. Circulation 1994; 90: 1679-87.
14. Mac Mahon S, Sharpe N, Gamble G, et al. Effects of lowering average or below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group. Circulation 1998; 97: 1784-90.
15. Fabris F, Zanocchi M, Bo M, et al. Carotid plaque, aging and risk factors. A study of 457 subjects. Stroke 1994; 25: 1133-40.
16. Salonen R, Nyyssonen K, Porkkala E, et al. Kuopio Atherosclerosis Prevention Study (KAPS). Circulation 1995; 92: 1758-64.
17. Blankenhorn DH, Selzer RH, Crawford DW, et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Circulation 1993; 88: 20-8.
18. Hodis HN, Mack WJ, LaBree L, et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy. Ann Intern Med 1996; 124: 549-56.
19. Fuster V. Elucidation of the role plaque instability and rupture in acute coronary events. Am J Cardiol 1995; 76: 24-33.
20. Hernández Perera O, Pérez Sala D, Navarro Antolín J, Sánchez Pascuala R, Hernández G, Díaz C, et al. Effects of the 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endotelial cells. J Clin Invest 1998; 101: 2711-9.
21. Vaughan CJ, Murphy MB, Buckley BM. Statins do more than just lower cholesterol. Lancet 1996; 348: 1079-82.
22. Delanty M, Vaughan CJ. Vascular effect of statins on stroke. Stroke 1997; 28: 2315-20.
23. Iso H, Jacobs DR, Wentworth D, Neaton JD, Cohen JD for the MRFIT research group. Serum cholesterol levels and six year mortality from stroke in 350,977 men screened for the Multiple Risk factor Intervention Trial. N Engl J Med 1989; 320: 904-10.
24. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 1995; 346: 1647-53.
25. Kagan A, Mc Gee DL, Rhoads GG, Nomura A. Serum cholesterol and mortality in a Japanese-American population: Honolulu Heart Program. Am J Epidemiol 1981; 114: 11-20.
26. Lawn MR, Thompson SG, Wald NJ. Assessing possible hazards of reducing serum cholesterol. Br Med J 1997; 308: 373-9.
27. Dyker AG, Weir CJ, Kennedy RL. Influence of cholesterol on survival after stroke: retrospective study. Br Med J 1997; 314: 1584-8.
28. Wilt TJ, Rubins HB, Robins SJ, et al. Carotid atherosclerosis in men with low levels of HDL cholesterol. Stroke 1997; 28: 1919-25.